Pinkerton Retirement Specialists’s Bristol-Myers Squibb BMY Stock Holding History

Pinkerton Retirement Specialists’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,424	Closed	-$318K	–	138
2022 Q4	$318K	Buy	+4,424	New	+$334K	0.07%	107
2018 Q4	–	Sell	-200	Closed	-$12K	–	68
2018 Q3	$12K	Hold	200	–	–	﹤0.01%	136
2018 Q2	$11K	Hold	200	–	–	﹤0.01%	143
2018 Q1	$13K	Sell	200 -658	-77%	-$42.3K	0.01%	130
2017 Q4	$53K	Buy	858 +658	+329%	+$41.2K	0.02%	84
2017 Q3	$13K	Hold	200	–	–	0.01%	112
2017 Q2	$11K	Hold	200	–	–	0.01%	124
2017 Q1	$11K	Sell	200 -267	-57%	-$14.6K	0.01%	88
2016 Q4	$27K	Sell	467 -4,267	-90%	-$233K	0.01%	267
2016 Q3	$523K	Buy	4,734 +4,126	+679%	+$265K	0.22%	72
2016 Q2	$45K	Buy	608 +374	+160%	+$26.4K	0.02%	201
2016 Q1	$15K	Buy	234 +34	+17%	+$2.14K	0.01%	78
2015 Q4	$14K	Hold	200	–	–	0.01%	68
2015 Q3	$12K	Sell	200 -34	-15%	-$2.16K	0.02%	84
2015 Q2	$16K	Buy	+234	New	+$15.4K	0.01%	82

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Pinkerton Retirement Specialists's BMY Position: Q1 2023 in Review

Pinkerton Retirement Specialists sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 4,424 shares — an estimated $318K sold.

Pinkerton Retirement Specialists first reported a position in BMY in Q2 2015 and held it in 15 quarters. The position peaked at $523K in Q3 2016. 2,543 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Pinkerton Retirement Specialists reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Pinkerton Retirement Specialists sold 4,424 Bristol-Myers Squibb shares in Q1 2023, an estimated $318K.
Pinkerton Retirement Specialists first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 15 quarters.
Pinkerton Retirement Specialists's Bristol-Myers Squibb position peaked at $523K in Q3 2016.
2,543 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2023, filed 11 May 2023.